EZH2 and hepatocellular carcinoma: To further uncover the role of EZH2 in HCC, a Y731D (tyrosine-to-aspartic acid substitution at amino acid 731) mutant of EZH2 was employed which completely impaired EZH2 catalytic activity and was unable to regulate H3K27 methylation21.